Institute of Oncology Ljubljana
98
21
34
43
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 98 trials
100.0%
+13.5% vs industry average
1%
1 trials in Phase 3/4
9%
4 of 43 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (98)
Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme
Role: lead
Endocrine and Metabolic Late Effects After Childhood Brain Tumor Treatment
Role: lead
Use of AlignRT System During Stereotactic Radiosurgery
Role: lead
Resting Energy Expenditure by Gastrointestinal Functional Status
Role: lead
Individual Approach in Gynecological Cancer Brachytherapy
Role: lead
ctDNA and TEP Levels in Colon Cancer
Role: lead
Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation in Colorectal Cancer Surgery
Role: lead
Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence
Role: lead
Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer
Role: lead
ProspectiveFemaleAYA - Late Effects of Cancer Therapies on Gonadal Function, Fertility, Efficiency of Fertility Preservation Procedures and Pregnancy Outcomes
Role: collaborator
Circulating Tumor DNA in Melanoma Patients
Role: lead
Sarcopenia Risk Screening in Patients With Gastrointestinal Cancer Using SARC-F
Role: lead
Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST)
Role: lead
Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers
Role: lead
Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)
Role: collaborator
Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity
Role: collaborator
Late Endocrine and Metabolic Consequences After Childhood Brain Tumor Treatment
Role: lead
Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study)
Role: lead
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Role: lead
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
Role: lead